Orion Oyj

(PINK:ORINY)

Latest On Orion Oyj (ORINY):

Date/Time Type Description Signal Details
2024-03-21 06:03 ESTDividendA dividend of $0.44 has been announced on Feb 27, 2024. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 21, 2024.Neutral
2023-03-23 11:59 ESTNewsBayer, Orion begin phase 3 trial of Nubeqa to expand prostate cancer indicationN/A
2023-03-23 06:01 ESTDividendA dividend of $0.85 has been announced on Feb 10, 2023. It will be paid Apr 17, 2023 with an ex-dividend date of Mar 23, 2023.Neutral
2023-03-01 20:21 ESTNewsOrion wins EU approval for darolutamide for additional indication in prostate cancerN/A
2023-02-27 09:18 ESTNewsOrion wins approval for darolutamide in Japan for metastatic prostate cancerN/A
2022-07-16 00:06 ESTNewsOrion Oyj (ORINF) CEO Timo Lappalainen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-07-15 06:55 ESTNewsOrion Oyj 2022 Q2 - Results - Earnings Call PresentationN/A
2022-06-15 19:25 ESTNewsOrion acquires Inovet’s animal health business for ~EUR 130M debt freeN/A
2022-05-01 03:34 ESTNewsOrion Oyj (ORINF) CEO Timo Lappalainen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-24 06:02 ESTDividendA dividend of $0.85 has been announced on Feb 11, 2022. It will be paid Apr 18, 2022 with an ex-dividend date of Mar 24, 2022.Neutral
2021-03-26 06:04 ESTDividendA dividend of $0.91 has been announced on Nov 30, -0001. It will be paid Apr 22, 2021 with an ex-dividend date of Mar 26, 2021.Neutral
2021-02-10 13:17 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 23:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 02:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 19:48 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 15:26 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:29 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 15:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 19:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 07:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 17:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 15:06 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:53 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 11:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 19:00 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:48 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:53 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 07:01 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:34 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:38 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 03:19 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 06:16 ESTDividendA dividend of $0.81 has been announced on Apr 22, 2020. It will be paid Jun 1, 2020 with an ex-dividend date of May 7, 2020.Neutral
2020-05-06 07:56 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:49 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 06:46 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:36 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 22:43 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 23:12 ESTFinancialsCompany financials have been released.Neutral
2020-03-26 06:07 ESTDividendA dividend of $0.83 has been announced on Mar 2, 2020. It will be paid Apr 20, 2020 with an ex-dividend date of Mar 26, 2020.Neutral
2020-03-25 22:42 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 06:16 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 00:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:50 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 01:20 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:37 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:50 ESTFinancialsCompany financials have been released.Neutral

About Orion Oyj (ORINY):

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company has a collaboration with Nanoform to apply Nanoform's CESS technology to new chemical entities. It serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) line of inhalers for asthma and COPD to Propeller's digital medicine platform. Orion Oyj is headquartered in Espoo, Finland.

See Advanced Chart

General

  • Name Orion Oyj
  • Symbol ORINY
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 3,311
  • Fiscal Year EndDecember
  • Web URLhttp://www.orion.fi
View More

Valuation

  • Trailing PE 21.89
  • Forward PE 28.9
  • Price/Sales (Trailing 12 Mt.) 4.49
  • Price/Book (Most Recent Quarter) 6.62
  • Enterprise Value Revenue 5.17
  • Enterprise Value EBITDA 16.6
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 20%
  • Return on Assets 16%
  • Return on Equity 29%
  • Earnings Per Share $1.37
  • Revenue Per Share $0
  • Gross Profit 651.1 million
  • Quarterly Earnings Growth -7%
View More

Highlights

  • Market Capitalization 5.89 billion
  • Book Value Per Share $3.05
View More

Share Statistics

  • Shares Outstanding 280.93 million
  • Shares Float 253.71 million
  • % Held by Insiders <1%
View More

Technicals

  • Beta 0.5
  • 52 Week High $27
  • 52 Week Low $17.04
  • 50 Day Moving Average 21.28
  • 200 Day Moving Average 22.77
View More

Dividends

  • Forward Annual Dividend Rate $0.91
  • Forward Annual Dividend Yield 4.43%
  • Payout Ratio 187%
  • Dividend Date 2021-04-22
  • ExDividend Date 2021-03-26
  • Dividend Per Share $0.91
  • Dividend Yield 0%
View More

Orion Oyj (ORINY) Dividend Calendar:

ORINY's last dividend payment was made to shareholders on April 22, 2021.
Orion Oyj pays out 187% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Orion Oyj (ORINY) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A$0.11
2020-09-302020-12-31$250.3 million$0.22
2020-06-302020-09-30$292.5 million$0.43
2020-03-312020-06-30$279.9 million$0.61
2019-12-312020-03-31$274.5 million$0.53
2019-09-302019-12-31$283.7 million$0.36
2019-06-302019-09-30$251.7 million$0.56
2019-03-312019-06-30$241 million$0.33
2018-12-312019-03-31$262.4 million$0.34
2018-09-302018-09-30$221.8 million$0.14
2018-06-302018-09-30$246.1 million$0.28
2018-03-312018-06-30$247.2 million$0.46
2017-12-312018-03-31$280.3 million$0.47
2017-09-302017-12-31$252.7 million$0.46
2017-06-302017-09-30$272.4 million$0.35
2017-03-312017-06-30$279.2 million$0.45
2016-12-312017-03-31$279.9 million$0.51
2016-09-302016-12-31$0.36
2016-06-302016-09-30$0.58
2016-03-312016-06-30$0.52
2015-12-312016-03-31$0.51
2015-09-302015-12-31$0.30
2015-06-302015-09-30$0.36
2015-03-312015-06-30$0.46
2014-12-312015-03-31$0.50
2014-09-302014-12-31$0.35$0.00
2014-06-302014-09-30$0.44$0.00
2014-03-312014-06-30$0.66$0.00
2013-12-312014-03-31$0.51$0.00
2013-09-302013-12-31$0.54$0.00
2013-06-302013-09-30$0.47$0.00
2013-03-312013-06-30$0.42$0.00
2012-12-312013-03-31$0.50$0.00
2012-09-302012-12-31$0.39$0.00
2012-06-302012-09-30$0.51$0.00
2012-03-312012-06-30$0.44$0.00
2011-12-312012-03-31$0.56$0.00
2011-09-302011-12-31$0.42$0.00
2011-06-302011-09-30$0.46$0.00
2011-03-312011-06-30$0.49$0.00
2010-12-312011-03-31$0.69$0.00
2010-09-302010-12-31$0.35$0.00

Orion Oyj (ORINY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Orion Oyj (ORINY) Chart:

Orion Oyj (ORINY) News:

Below you will find a list of latest news for Orion Oyj (ORINY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Orion Oyj (ORINY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Orion Oyj (ORINY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link